Grandview Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Grandview Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-450	Closed	-$248K	–	121
2022 Q4	$248K	Sell	450 -5	-1%	-$2.65K	0.15%	106
2022 Q3	$231K	Sell	455 -100	-18%	-$56K	0.15%	109
2022 Q2	$302K	Sell	555 -59	-10%	-$32.5K	0.17%	97
2022 Q1	$363K	Hold	614	–	–	0.15%	106
2021 Q4	$410K	Buy	+614	New	+$383K	0.16%	100
2021 Q3	–	Sell	-603	Closed	-$304K	–	108
2021 Q2	$304K	Sell	603 -154	-20%	-$72.7K	0.17%	90
2021 Q1	$346K	Buy	757 +47	+7%	+$22.4K	0.18%	102
2020 Q4	$331K	Buy	+710	New	+$333K	0.22%	92

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Grandview Asset Management's TMO Position: Q1 2023 in Review

Grandview Asset Management sold out of Thermo Fisher Scientific (TMO) in Q1 2023, closing a stake of 450 shares — an estimated $248K sold.

Grandview Asset Management first reported a position in TMO in Q4 2020 and held it in 8 quarters. The position peaked at $410K in Q4 2021. 2,386 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

Grandview Asset Management reported no remaining Thermo Fisher Scientific position as of Q1 2023 after selling out during the quarter.
Grandview Asset Management sold 450 Thermo Fisher Scientific shares in Q1 2023, an estimated $248K.
Grandview Asset Management first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 8 quarters.
Grandview Asset Management's Thermo Fisher Scientific position peaked at $410K in Q4 2021.
2,386 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Grandview Asset Management's 13F filing for Q1 2023, filed 13 Apr 2023.